CM Asia Nail With AS2 Without AS2 (AS2 Study)

September 8, 2020 updated by: Zimmer Biomet

Randomized Controlled Study Comparing Zimmer Natural Nail System Cephalomedullary Asia Nail With Anterior Support Screw (AS2) Versus Conventional Technique

The purpose of this study is to compare reduction positon maintenance rate at 3 weeks post-operatively between patients operated with Anterior Support Screw (AS2) and without AS2 technique in RCT setting. Total 240 cases(each arm 120 cases) will be enrolled at maximum 15sites, total study duration is 22months.

Study Overview

Detailed Description

Objective: To compare fracture reduction maintenance rate at 2-3weeks post-operatively between patients operated with AS2 (investigational group) and patients operated without AS2 (Control group) using same implant system (ZNN CM Asia, Zimmer Biomet).

Endpoint: Primary: The rate of reduction position maintenance at 2-3 weeks post-operatively. Secondary: Surgery time / fracture type / postoperative reduction position / CT assessment / Safety information

Study Type

Interventional

Enrollment (Actual)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Fukuoka, Japan, 815-8588
        • Kyushu Central Hospital
      • Kumamoto, Japan, 861-4193
        • Saiseikai Kumamoto Hospital
      • Niigata, Japan, 950-8556
        • Niigata Central Hospital
      • Okayama, Japan, 702-8055
        • Okayama Rosai Hospital
      • Okayama, Japan, 700-8607
        • Okayama Red Cross Hospital
      • Saga, Japan, 840-8571
        • Saga Pref. Medical Centre Koseikan
    • Hiroshima
      • Kure, Hiroshima, Japan, 737-8505
        • Kure Kyosai Hospital
    • Hyogo
      • Toyooka, Hyogo, Japan, 668-8501
        • Toyooka Hospital
    • Kasugai
      • Aichi, Kasugai, Japan, 486-8510
        • Kasugai Municipal Hospital
    • Osaka
      • Hirakata, Osaka, Japan, 573-8511
        • Hoshigaoka Medical Center
    • Shizuoka
      • Numazu, Shizuoka, Japan, 410-0302
        • Numazu City Hospital
    • Toyama
      • Takaoka, Toyama, Japan, 933-8525
        • Saiseikai Takaoka Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

In order to be eligible to participate in this study, a subject must meet all of the following criteria.

  • Eligible for intramedullary nailing.
  • Fracture type is classified as 3-partB or 4-part fracture in 3D-CT (Three Dimensional Computed Tomography) classification (Nakano), and combination with a subtype P in lateral classification (Ikuta) at preoperative CT (Computed Tomography) assessment.(In the case of classified in radiograph (X-ray) at preoperative: Classified as Type 4 or Type 5 in Jensen classification, and combination of subtype P in lateral classification (Ikuta))
  • Japanese Male or female
  • > 20 years of age
  • Primary closed intertrochanteric fracture of the femur
  • Subjects willing to return for follow-up evaluations.

Exclusion Criteria:

A potential subject who meets any of the following criteria will be excluded from participation in this study.

  • Patient who cannot take CT image within 3 days and 2-3weeks after surgery.
  • Uncooperative patient or patient with neurologic disorders who are incapable of following directions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ZNN CM Asia with AS2 technique

Open Reduction and Internal Fixation with AS2 Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail.

Bone fragment will be stabilized by additional screw fixation (Anterior Support Screw).

Fractured bone fragments are reduced and stabilized by intramedullary nail.
Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.
Experimental group will receive insertion of ACE 4.5/5.0mm cannulated lag-screw anteriorly to Zimmer Natural Nail CM Asia Lag-screw.
Other Names:
  • ACE 4.5/5.0mm cannulated lag-screw
Active Comparator: ZNN CM Asia without AS2 technique
Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail without additional screw fixation.
Fractured bone fragments are reduced and stabilized by intramedullary nail.
Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Patient With and Without Excessive Lag Screw Sliding Distance
Time Frame: Postoperative 2-3 week
Number of patient was counted based on CT measurement results. Relative position of lag screw between CT images taken at both immediate and 2-3 weeks postoperatively was measured and recorded in value (e.g., 1.5 mm). This was called as "lag screw sliding distance". Four millimeter was set as threshold to define success and failure. Less than 4mm of lag screw sliding distance was recognized as Success and equal to or more than 4mm of lag screw sliding distance was recognized as Failure.
Postoperative 2-3 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgery Time
Time Frame: Intraoperative, an average of 1 hour
Surgery time from skin incision to closure
Intraoperative, an average of 1 hour
Image Assessment Using Computed Tomography (CT)
Time Frame: 2-3 weeks postoperatively

Number of patient was counted based on CT measurement results. When the fracture reduction position achieved at surgery was maintained at 2 to 3 weeks, then the patient was categorized as success (Reduction position maintained). On the other hand, patient was categorized as failure (Reduction position changed) in the case that the fracture reduction position was changed.

Fracture repair position was categorized into three; "Anterior", "Neutral" or "Posterior" based on relative position of proximal bone fragment and distal bone fragment.

This analysis only includes patients whose fracture reduction position at immediate postoperative CT was either "Anterior" or "Neutral".

If both immediate and 2-3 weeks postoperative CT images show same fracture reduction position (example: "Anterior" at immediate postoperatively & "Anterior" at 2-3 weeks postoperatively), then the patient was recognized as Success (Reduction position maintained).

2-3 weeks postoperatively
Intraoperative Safety
Time Frame: Intraoperative
This is to evaluate whether any adverse events specific to insert additional screw for AS2 technique were occurred.
Intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Takashi Maehara, MD, Ph. D, Kagawa Rosai Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2017

Primary Completion (Actual)

April 2, 2020

Study Completion (Actual)

April 9, 2020

Study Registration Dates

First Submitted

March 28, 2017

First Submitted That Met QC Criteria

June 20, 2017

First Posted (Actual)

June 22, 2017

Study Record Updates

Last Update Posted (Actual)

September 29, 2020

Last Update Submitted That Met QC Criteria

September 8, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • T.CR.I.AP.16.4

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trochanteric Fracture of Femur

Clinical Trials on Open Reduction and Internal Fixation

Subscribe